ATE195931T1 - Enantioselektive herstellung von optisch reinem albuterol - Google Patents
Enantioselektive herstellung von optisch reinem albuterolInfo
- Publication number
- ATE195931T1 ATE195931T1 AT95919913T AT95919913T ATE195931T1 AT E195931 T1 ATE195931 T1 AT E195931T1 AT 95919913 T AT95919913 T AT 95919913T AT 95919913 T AT95919913 T AT 95919913T AT E195931 T1 ATE195931 T1 AT E195931T1
- Authority
- AT
- Austria
- Prior art keywords
- optically pure
- albuterol
- enantioselective production
- pure albuterol
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/34—Preparation of optical isomers by separation of optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/247,302 US5399765A (en) | 1994-05-23 | 1994-05-23 | Enantioselective preparation of optically pure albuterol |
| US08/376,072 US5545745A (en) | 1994-05-23 | 1995-01-20 | Enantioselective preparation of optically pure albuterol |
| PCT/US1995/006539 WO1995032178A1 (en) | 1994-05-23 | 1995-05-23 | Enantioselective preparation of optically pure albuterol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE195931T1 true ATE195931T1 (de) | 2000-09-15 |
Family
ID=26938588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95919913T ATE195931T1 (de) | 1994-05-23 | 1995-05-23 | Enantioselektive herstellung von optisch reinem albuterol |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5545745A (de) |
| EP (1) | EP0763010B1 (de) |
| JP (1) | JP3826208B2 (de) |
| AT (1) | ATE195931T1 (de) |
| AU (1) | AU686386B2 (de) |
| DE (1) | DE69518646T2 (de) |
| DK (1) | DK0763010T3 (de) |
| ES (1) | ES2151065T3 (de) |
| GR (1) | GR3034982T3 (de) |
| PT (1) | PT763010E (de) |
| WO (1) | WO1995032178A1 (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136327A (en) | 1997-12-01 | 2000-10-24 | Alza Corporation | Stereospecific delivery of a drug using electrotransport |
| US6365756B1 (en) * | 1998-02-20 | 2002-04-02 | Fine Chemical Corporation Limited | Process for the production of optically enriched (R)- or (S)-albuterol |
| ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
| US7232837B2 (en) * | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
| US6451289B2 (en) * | 2000-03-24 | 2002-09-17 | Sepracor Inc. | Albuterol formulations |
| GB0030171D0 (en) * | 2000-12-11 | 2001-01-24 | Cipla Ltd | Process for preparing isomers of salbutamol |
| US6596686B2 (en) | 2001-03-12 | 2003-07-22 | International Flavors & Fragrances Inc. | Use of dihydropyrans as fragrance Material |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| DK1572622T3 (da) * | 2002-12-10 | 2006-08-28 | Sepracor Inc | Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator |
| WO2004101592A1 (ja) * | 2003-05-19 | 2004-11-25 | Taisho Pharmaceutical Co., Ltd. | エリスロマイシンａ誘導体の製造方法 |
| US20050020692A1 (en) * | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
| NZ547178A (en) * | 2003-11-20 | 2008-06-30 | Alteragon Pty Ltd | Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol |
| CA2556920A1 (en) * | 2004-05-20 | 2005-12-01 | Teva Pharmaceutical Fine Chemicals S.R.L. | Levalbuterol hydrochloride polymorph a |
| DE102004054054A1 (de) * | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| RU2440972C2 (ru) * | 2004-12-17 | 2012-01-27 | Сипла Лимитед | Кристаллический сульфат левосальбутамола, способ его получения и фармацевтическая композиция, содержащая его |
| US20090263333A1 (en) * | 2004-12-17 | 2009-10-22 | Cipla Limited | Pharmaceutical compounds and compositions |
| EP1832572A1 (de) * | 2006-03-08 | 2007-09-12 | Stirling Products Limited | Verfahren zur Enantiomerenanreicherung von Salbutamol und von Salbutamolvorläufern |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| CA2810522A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Polymorphs |
| EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
| ES2431844T3 (es) | 2006-08-02 | 2013-11-28 | Aarti Healthcare Limited | Procedimiento para la preparación de (R)-(-)-salbutamol ópticamente puro y sus sales farmacéuticamente aceptables |
| EP1935872A1 (de) * | 2006-12-11 | 2008-06-25 | Stirling Products Limited | Verfahren zur Gewinnung des R-Enantiomers von Salbutamol |
| AU2008331928B2 (en) * | 2007-12-03 | 2012-08-16 | Bridge Pharma, Inc. | Use of RR/SR-ractopamine |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CA2741700A1 (en) * | 2008-10-24 | 2010-04-29 | Biolink Life Sciences, Inc. | Stable, water-insoluble r-(+)-.alpha.-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
| BRPI0923121A2 (pt) | 2008-12-23 | 2015-08-11 | Boehringer Ingelheim Int | Formas salinas de compostos orgânico |
| TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
| ES2760917T3 (es) | 2009-11-27 | 2020-05-18 | Boehringer Ingelheim Int | Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina |
| JP6034781B2 (ja) | 2010-05-05 | 2016-11-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 併用療法 |
| CA3164653A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | A combination comprising linagliptin and a long-acting insulin |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| EP2849755A1 (de) | 2012-05-14 | 2015-03-25 | Boehringer Ingelheim International GmbH | Xanthinderivat als dpp-4-hemmer zur verwendung bei der behandlung von durch podozyten vermittelten erkrankungen und/oder des nephrotischen syndroms |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP3033327B1 (de) * | 2013-08-15 | 2018-01-03 | Allergan, Inc. | (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one(l)-(+)-tartratsalz, dessen verfahren zur herstellung und verwendung |
| EP3110449B1 (de) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medizinische verwendung eines dpp-4-inhibitors |
| EP3042892A1 (de) | 2015-01-09 | 2016-07-13 | Deva Holding Anonim Sirketi | Amorphisierung von Levosalbutamoltartrat |
| JP2019517542A (ja) | 2016-06-10 | 2019-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | リナグリプチンおよびメトホルミンの組合せ |
| KR20230081285A (ko) * | 2021-11-30 | 2023-06-07 | 주식회사 브이에스팜텍 | 고순도의 1-(1-(2-벤질페녹시)프로판-2-일)-2-메틸피페리딘 단일 이성질체의 제조방법 |
| CN115286521B (zh) * | 2022-07-11 | 2023-11-03 | 上海医药集团(本溪)北方药业有限公司 | 一种盐酸左沙丁胺醇的合成方法 |
| CN116836069B (zh) * | 2023-06-02 | 2024-01-30 | 山东锐顺药业有限公司 | 一种盐酸左沙丁胺醇的制备方法 |
| CN116693406B (zh) * | 2023-06-02 | 2024-04-19 | 山东锐顺药业有限公司 | 一种硫酸沙丁胺醇的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283359A (en) * | 1990-09-11 | 1994-02-01 | Schering Corp. | Process for preparing albuterol, acetal, hemi-acetal, and hydrates of arylglyoxal intermediates thereof |
-
1995
- 1995-01-20 US US08/376,072 patent/US5545745A/en not_active Expired - Lifetime
- 1995-05-23 AU AU25559/95A patent/AU686386B2/en not_active Expired
- 1995-05-23 WO PCT/US1995/006539 patent/WO1995032178A1/en active IP Right Grant
- 1995-05-23 JP JP53051395A patent/JP3826208B2/ja not_active Expired - Lifetime
- 1995-05-23 EP EP95919913A patent/EP0763010B1/de not_active Expired - Lifetime
- 1995-05-23 AT AT95919913T patent/ATE195931T1/de active
- 1995-05-23 PT PT95919913T patent/PT763010E/pt unknown
- 1995-05-23 ES ES95919913T patent/ES2151065T3/es not_active Expired - Lifetime
- 1995-05-23 DK DK95919913T patent/DK0763010T3/da active
- 1995-05-23 DE DE69518646T patent/DE69518646T2/de not_active Expired - Lifetime
-
2000
- 2000-11-24 GR GR20000402605T patent/GR3034982T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0763010A1 (de) | 1997-03-19 |
| WO1995032178A1 (en) | 1995-11-30 |
| DK0763010T3 (da) | 2001-01-08 |
| JP3826208B2 (ja) | 2006-09-27 |
| GR3034982T3 (en) | 2001-02-28 |
| JPH10500954A (ja) | 1998-01-27 |
| AU686386B2 (en) | 1998-02-05 |
| PT763010E (pt) | 2000-12-29 |
| US5545745A (en) | 1996-08-13 |
| DE69518646T2 (de) | 2001-04-19 |
| EP0763010B1 (de) | 2000-08-30 |
| DE69518646D1 (de) | 2000-10-05 |
| AU2555995A (en) | 1995-12-18 |
| ES2151065T3 (es) | 2000-12-16 |
| EP0763010A4 (de) | 1997-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE195931T1 (de) | Enantioselektive herstellung von optisch reinem albuterol | |
| DE69713374D1 (de) | Verfahren zur herstellung von optisch reinen isomeren des formoterols | |
| MX9203346A (es) | (+)-1-(3-dimetilaminopropil)-1-(4'-fluorfenil)-1,3-dihidro-sobenofuran -5-carbonitrilo y sus sales de adicion de acido no toxicas farmaceuticamente utiles. | |
| DE69525840D1 (de) | Herstellung von arthropodiziden oxadiazinen | |
| DE59813589D1 (de) | Verfahren zur Herstellung von optisch aktiven Aminoalkoholen durch Racematspaltung | |
| FI894022A0 (fi) | Menetelmä (2R,3S)-3-(4-metoksifenyyli)glysidiinihapon alemman alkyyliesterin valmistamiseksi | |
| Bianchi et al. | Enzymic hydrolysis of alkyl 3, 4-epoxybutyrates. A new route to (R)-(-)-carnitine chloride | |
| ES2128959A1 (es) | Procedimiento de separacion de carbinoles. | |
| HU903056D0 (en) | Method for producing optically active ceramide type compounds | |
| CA2190577A1 (en) | Enantioselective preparation of optically pure albuterol | |
| ATE144519T1 (de) | Phosphinesterhaltige n-acyl-2-aminosäureamide, verfahren zu ihrer herstellung und n-acyl-2- aminosäurenitrile als vorprodukte | |
| EP0808824A3 (de) | Verfahren zur Herstellung von optisch aktiven Estern der 2-Halogen-3-Hydroxypropionsäure | |
| TW341559B (en) | Process for racemization of optically active 1-phenylethylamine derivative | |
| DK0549710T3 (da) | Fremgangsmåde til fremstilling af enantiomere 2-alkansyrer | |
| Kataoka et al. | Stereospecific reduction of ethyl 2′-ketopantothenate to ethyl d-(+)-pantothenate with microbial cells as a catalyst | |
| EP1340743A4 (de) | Optisch aktives aminderivat und syntheseverfahren | |
| BR0008586A (pt) | Processo de preparação de aminoácidos quirais e processo de preparação de compostos a partir destes | |
| DE69803636D1 (de) | Verfahren zur Herstellung von (1S,2R)-1-Amino-2-indanol-(R,R)-tartrate methanol Solvat | |
| ATE212381T1 (de) | Optische trennung von alkyl 1,4-benzodioxan-2- carboxylaten mit einer esterase aus serratia marcescens | |
| ATE159246T1 (de) | Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba | |
| BR8701422A (pt) | Processo para separacao biotecnologica,efetuada por meio de enzimas,de isomeros opticos(r)e(s)de 2-amino-1 alcanois racemicos | |
| DE59803008D1 (de) | Verfahren zur Herstellung von Ethinylcyclopropan | |
| GB1560907A (en) | Process or racemizing an optically active phenyl glycine amide with or without a substituted phenyl group | |
| EP0795609A3 (de) | Verfahren zur Herstellung von optisch-aktiven Trans-3-Phenylglycidamid-Verbindungen | |
| DE69913517D1 (de) | Verfahren zur herstellung einer kristallsuspensionhenonen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |